Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations.
Cancer Discov. 2023 Mar 1;13(3):598-615. doi: 10.1158/2159-8290.CD-22-0968.
Cancer Discov. 2023.
PMID: 36511802
Free PMC article.
Discovery and Validation of a Compound to Target Ewing's Sarcoma.
Esfandiari Nazzaro E, Sabei FY, Vogel WK, Nazari M, Nicholson KS, Gafken PR, Taratula O, Taratula O, Davare MA, Leid M.
Esfandiari Nazzaro E, et al. Among authors: nicholson ks.
Pharmaceutics. 2021 Sep 24;13(10):1553. doi: 10.3390/pharmaceutics13101553.
Pharmaceutics. 2021.
PMID: 34683845
Free PMC article.
Item in Clipboard
Functional impact and targetability of PI3KCA, GNAS, and PTEN mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation.
Choo F, Odintsov I, Nusser K, Nicholson KS, Davis L, Corless CL, Stork L, Somwar R, Ladanyi M, Davis JL, Davare MA.
Choo F, et al. Among authors: nicholson ks.
Cold Spring Harb Mol Case Stud. 2022 Jan 10;8(1):a006140. doi: 10.1101/mcs.a006140. Print 2022 Jan.
Cold Spring Harb Mol Case Stud. 2022.
PMID: 35012940
Free PMC article.
Item in Clipboard
Cite
Cite